Report ID: SQMIG35J2043
Report ID:
SQMIG35J2043 |
Region:
Global |
Published Date: February, 2024
Pages:
224
|
Tables:
92 |
Figures:
76
Microbiome Market size was valued at USD 743.21 Billion in 2023 and is poised to grow from USD 963.27 Billion in 2024 to USD 7671.11 Billion by 2032, growing at a CAGR of 29.61% during the forecast period (2025-2032).
Microbiome is a collection of microorganisms that live on and within our bodies. The United States National Institutes of Health (NIH) started the Human Microbiome Project to increase understanding of the microbial flora involved in human health and disease. The market is expanding as a result of factors such as an increase in the number of strategic alliances for microbiome therapies for R&D, product development, the anticipated introduction of innovative medications, and portfolio enhancement. For example, Hudson Institute and BiomeBank announced a four-year agreement in January 2022 to develop and discover microbial treatments. Furthermore, the increasing prevalence of target diseases is driving up demand for microbiome therapies.
US Microbiome Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2043